XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 38 filers reported holding XENON PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,893,861 | -22.5% | 48,573 | -14.4% | 0.01% | +14.3% |
| Q1 2024 | $2,443,088 | -25.3% | 56,750 | -20.1% | 0.01% | -36.4% |
| Q4 2023 | $3,270,859 | +48.6% | 71,013 | +10.2% | 0.01% | +37.5% |
| Q3 2023 | $2,201,749 | -11.3% | 64,454 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $2,481,479 | +7.6% | 64,454 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $2,306,809 | -9.2% | 64,454 | 0.0% | 0.01% | -20.0% |
| Q4 2022 | $2,541,421 | +9.2% | 64,454 | 0.0% | 0.01% | +11.1% |
| Q3 2022 | $2,327,000 | +52.2% | 64,454 | -58.4% | 0.01% | +50.0% |
| Q2 2019 | $1,529,000 | -3.0% | 155,100 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $1,576,000 | +61.0% | 155,100 | 0.0% | 0.01% | +50.0% |
| Q4 2018 | $979,000 | -52.2% | 155,100 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $2,047,000 | +43.4% | 155,100 | 0.0% | 0.01% | +60.0% |
| Q2 2018 | $1,427,000 | +347.3% | 155,100 | +138.6% | 0.01% | +400.0% |
| Q1 2018 | $319,000 | +73.4% | 65,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $184,000 | -4.2% | 65,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $192,000 | -6.3% | 65,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $205,000 | -21.2% | 65,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $260,000 | -48.1% | 65,000 | 0.0% | 0.00% | -50.0% |
| Q4 2016 | $501,000 | -4.9% | 65,000 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $527,000 | +36.9% | 65,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $385,000 | -15.2% | 65,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $454,000 | -56.6% | 65,000 | -50.0% | 0.00% | 0.0% |
| Q4 2015 | $1,046,000 | +94.8% | 130,000 | +100.0% | 0.00% | 0.0% |
| Q3 2015 | $537,000 | -28.3% | 65,000 | 0.0% | 0.00% | -33.3% |
| Q2 2015 | $749,000 | – | 65,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,754,266 | $107,388,831 | 7.33% |
| Altium Capital Management LP | 360,600 | $14,059,794 | 5.74% |
| Affinity Asset Advisors, LLC | 994,227 | $38,764,911 | 4.47% |
| First Light Asset Management, LLC | 1,306,260 | $50,931,077 | 4.46% |
| Nan Fung Group Holdings Ltd | 106,680 | $4,159,453 | 4.44% |
| Ally Bridge Group (NY) LLC | 169,369 | $6,603,697 | 3.93% |
| TLS Advisors LLC | 32,956 | $1,285 | 3.22% |
| BRAIDWELL LP | 2,560,573 | $99,836,741 | 3.13% |
| Paradigm Biocapital Advisors LP | 2,043,280 | $79,667,487 | 3.05% |
| BRIDGER MANAGEMENT, LLC | 146,800 | $5,723,732 | 2.94% |